• SENSEX 74,902.59
    138.36 (+0.19%)
  • BANKNIFTY 56,295.55
    -482.00 (--0.85%)
  • Corona Remedies
    2,224.35 2,261.40(%)
  • Cams Services
    681.75 611.70(%)
  • ESDS Software
    1,560.35 1,418.50(%)
  • Power Grid Corpn
    272.00 324.80(%)
  • Avenue Super.
    3,664.10 3,528.65(%)
  • Molbio Diagnosti
    1,509.70 1,291.00(%)
  • Ather Energy
    1,661.80 1,741.90(%)
  • Reliance Industries
    1,267.00 1,250.55(%)
  • Hero Motocorp
    5,280.00 6,390.00(%)
  • HDFC Bank
    694.50 1,020.35(%)
  • Tata Motors PVeh
    300.10 294.15(%)
  • United Breweries
    1,254.00 1,245.10(%)
  • ASM Technologies
    7,248.00 6,990.00(%)
  • Swan Corp
    315.60 506.20(%)
  • Bharti Airtel
    1,848.80 2,174.70(%)
  • Swiggy
    278.75 235.85(%)
  • KEI Industries
    4,580.45 3,730.00(%)
  • Netweb Technol.
    5,047.00 5,810.00(%)
  • IFCI
    84.61 46.20(%)
  • Axis Bank
    1,260.00 1,418.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Astonea Labs Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 93643.0
  • ISIN : INE0TG901011
289.00 -6 (-1.97%)
  • As on 10 Sep 2026 (EOD)

  • Today’s Low

    281.05

  • Today’s High

    297.00

  • Open

    293.00

  • Perv Close

    294.80

  • 52W Low

    118.00

  • 52W High

    301.30

Key Indicators

  • P/E(TTM)

    67.21

  • Mar.Cap (₹Cr.)

    303.77

  • Div & Yield %

    0.00

  • Book Value(₹)

    54.35

  • Debt-Equity Ratio

    -1.97

  • AGM Date

    08-Sep-2026

  • EPS

    4.30

  • P/E Ratio

    67.21

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    303.77

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.51

  • BV (₹)

    54.40

  • Sales( ₹ in Cr.)

    147.58

  • NP (in Cr.)

    4.52

  • NP Var(%)

    -16.0

  • Div%

    0.0

  • CPS (₹)

    9.00

  • EPS (₹)

    4.30

  • Traded Value (₹ in Lakhs)

    303.77

  • 52 Week High

    301.30

  • 52 Week Low

    118.00

  • Price BSE

    289.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    303.77

  • P/C Ratio

    32.00

  • P/E Ratio

    67.30

  • Price Vs.BV

    4.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar
INCOME :            
Sales Turnover 147.58 97.52 80.19 67.05 30.06 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 147.58 97.52 80.19 67.05 30.06 -
Other Income 0.52 0.19 0.10 0.21 0.12 -
Stock Adjustments 4.40 0.22 2.11 2.47 -0.57 -
Total Income 152.50 97.93 82.40 69.73 29.61 -
EXPENDITURE :            
Raw Materials 102.79 66.89 58.49 52.53 18.49 -
Power and Fuel Cost 1.51 1.30 1.22 0.86 0.39 -
Employee Cost 6.31 5.84 4.96 3.26 1.88 -
Other Manufacturing Expenses 5.24 5.27 3.08 3.91 1.41 -
Selling and Administration Expenses 22.16 3.09 2.43 1.82 1.41 -
Miscellaneous Expenses 0.48 0.05 0.19 0.00 0.08 -
Employee Benefit Expenses 6.31 5.84 4.96 3.26 1.88 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 138.49 82.44 70.38 62.38 23.66 -
Operating Profit 14.02 15.48 12.02 7.35 5.95 -
Interest 3.41 3.83 2.97 2.34 1.58 -
Gross Profit 10.61 11.65 9.05 5.01 4.37 -
Depreciation 4.99 4.58 3.67 3.93 3.79 -
Profit Before Tax 5.62 7.07 5.38 1.08 0.58 -
Current Tax 1.69 1.99 1.63 0.57 0.31 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax -0.59 -0.27 -0.32 -0.15 0.02 -
Reported Net Profit 4.52 5.35 4.07 0.67 0.25 -
Extraordinary Items 0.00 0.00 0.00 0.08 0.00 -
Adjusted Net Profit 4.52 5.35 4.07 0.59 0.25 -
Adjustment below Net Profit -0.05 0.00 -3.60 0.00 0.12 -
P & L Balance brought forward 9.60 4.25 3.78 3.49 3.12 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.00 0.00 0.00 0.00 -
P & L Balance carried down 14.07 9.60 4.25 4.16 3.49 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 4.30 6.93 5.36 1.66 0.62 -
Earnings Per Share(Adj)-Unit Curr 4.30 - - - - -
Book Value 54.35 23.85 15.60 20.39 18.73 -
Book Value(Adj)-Unit Curr 54.35 - - - - -

Shareholding Pattern

  • Promoter Group

    72.30%

  • Public Share Holding

    27.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 7,599,970 72.30 7,599,970 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,599,970 72.30 7,599,970 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,000 0.07 7,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,000 0.07 7,000 1
2] Non Institution
Bodies Corporate 485,000 4.61 485,000 16
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,000 0.07 7,000 5
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 73,000 0.69 73,000 13
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,557,000 14.81 1,557,000 17
Individuals holding nominal share capital up to Rs. 1 lakh 782,030 7.44 782,030 320
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,904,030 27.63 2,904,030 371
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,511,000 100.00 10,511,000 376

Company Background

Astonea Labs LtdPharmaceuticals - Indian - Bulk Drugs

  • Astonea Labs Ltd
  • BSE Code : 93643.0
  • ISIN : INE0TG901011

  • Incorporation Year

    2017

  • Registered Office

    SCO 321-322 Basement Sector
    35B, Chandigarh,
    Chandigarh-160022

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    Ashish Gulati

  • Company Secretary

    Ankit Kapoor

  • Auditor

    Avnish Sharma & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Astonea Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Astonea Labs 289.00 148.10 147.58 67.21 10.47
Abbott India 25,223.40 7,217.19 6,929.05 33.20 43.78
Astrazeneca Phar 6,899.30 2,304.07 2,275.58 101.68 27.86
Glaxosmi. Pharma 2,886.15 3,932.76 3,790.20 46.10 58.17
Novartis India 2,188.00 393.10 354.33 55.25 15.94
Cipla 1,368.00 20,102.60 18,979.95 35.95 13.88
Bliss GVS Pharma 692.70 773.53 729.81 64.38 12.51
Amrutanjan Healt 504.05 520.13 502.55 27.00 24.16
Fermenta Biotec. 493.95 474.15 450.25 23.06 18.77
Guj. Themis Bio. 431.30 152.47 150.80 115.32 27.21
Ambalal Sarabhai 42.15 19.52 3.94 78.06 6.77